Biotech grants in Ireland

Closed

Administers research teams and institutions for PRECISEU Joint Interregional Projects on Personalised Medicine in medical technology, biotechnology, and artificial intelligence.

Closed

Pays one consortium to run a public-education and communication campaign on biotech-derived alternative proteins such as precision-fermentation foods.

Closed

Funds bio-based and nature-based reconstruction solutions for areas damaged by conflicts such as the wars in Ukraine and Gaza.

Closed

Funds transnational access to research infrastructure services in one of three areas — industrial biotechnology, radionuclide facilities, or climate prediction.

Funds retrofitting an existing industrial or biorefinery plant to produce higher-value bio-based chemicals or materials than its old process line.

Funds scale-up of protein extraction or production processes from alternative sources like plants, fungi, microorganisms or fermentation, aimed at food use.

Closed

Pays 75% (up to €75K) for satellite-based sustainable-pharma services.

Closed

Funds teams in Germany through a continuous hormone-monitoring challenge for advanced sensor development.

Funds scale-up of safe-and-sustainable bio-based polymers or co-polymers that match or beat fossil-based alternatives on performance.

Funds demonstration of safe-and-sustainable bio-based chemicals or processes that replace hazardous coatings, dyes and solvents used in making textiles.

Closed

Pays one consortium to run an EU-wide bioeconomy networking platform connecting researchers, investors, policymakers and businesses.

Closed

Funds projects that build shared taxonomy databases or a European biodiversity genomics network to speed up species identification.

Closed

Pays one consortium to align bioeconomy research funding and priorities across Central-Eastern Europe, Ukraine, Moldova and the Western Balkans.

Closed

Funds R&D into bio-based alternatives that replace hazardous chemicals like PFAS in industrial products and processes.

Funds companies scaling up sustainable macroalgae cultivation and turning the harvest into new bio-based food, feed or industrial products.

Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.

Closed

Funds clinical and pre-clinical research that pins down the causes of, and builds better diagnostics and treatments for, medical conditions that are common but poorly understood, such as ME/CFS, autism, gynaecological diseases and low back pain.

Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.

Closed

Pays biomedical New Approach Methodology developers a fixed EUR 300,000 lump-sum grant to validate animal-free testing methods and prepare them for regulatory use.

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.

Closed

Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.

Closed

Funds AI and digital-twin tools that speed up bio-based manufacturing — from biorefinery process control to predicting biosynthesis pathways.

Funds a full-scale flagship biorefinery that turns separately-collected urban bio-waste into higher-value bio-based products instead of compost or biomethane.

Closed

Funds the advancement of existing vaccine candidates against one named epidemic-prone virus, from lab testing through to a first human safety trial.